Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1700-1708
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1700
Table 1 General data of the two patient groups
Variable
LC + EPBD group (n = 50)
LC + EST group (n = 52)
t/χ2
P value
Age (year)57.22 ± 8.0358.19 ± 8.74-0.5840.560
Gender (male/female)25/2424/280.1510.698
BMI22.35 ± 3.2123.15 ± 3.91-1.1270.263
Size of bile duct stones (mm)8.18 ± 2.198.56 ± 2.57-0.7970.427
Diameter of the common bile duct (mm)11.84 ± 1.4012.12 ± 1.59-0.9250.357
Number of bile duct stones (n)3.02 ± 1.222.77 ± 1.171.0620.291
Table 2 Comparison of surgical success rates between the two groups, n (%)
Item
LC + EPBD group (n = 50)
LC + EST group (n = 52)
χ2
P value
Significantly effective38 (76.00)37 (71.20)0.5270.768
Effective9 (18.00)10 (19.20)
Ineffective3 (6.00)5 (9.60)
Surgical success rate47 (94.00)44 (90.40)
Table 3 Surgery-related indicators in the two groups
Item
LC + EPBD group (n = 50)
LC + EST group (n = 52)
t/χ2
P value
Total operation time (min)94.16 ± 14.3292.37 ± 12.850.6670.507
Intraoperative hemorrhage (mL)32.98 ± 8.9537.48 ± 8.85-2.5540.012
Rate of conversion to laparotomy, n (%)00//
Success rate of stone extraction, n (%)48 (96.00)49 (94.20)1.000
Stone removal rate, n (%)48 (96.00)50 (96.20)1.000
Table 4 Comparison of postoperative recovery between the two groups
Item
LC + EPBD group (n = 50)
LC + EST group (n = 52)
t
P value
VAS score3.06 ± 0.743.21 ± 0.87-0.9450.347
Time to postoperative exhaust (d)1.34 ± 0.631.42 ± 0.67-0.6480.519
Time to ambulation (d)1.32 ± 0.621.82 ± 0.51-4.502< 0.001
Hospitalization time (d)11.52 ± 1.7611.98 ± 1.48-1.4330.155
Table 5 Comparison of complications after surgery in the two groups, n (%)
Item
LC + EPBD group (n = 50)
LC + EST group (n = 52)
χ2
P value
Pancreatitis3 (6.00)2 (3.80)0.675
Cholangitis1 (2.00)2 (3.80)1.000
Abdominal infection 01 (1.90)1.000
Death00/
Perforation00/
Overall complications4 (8.00)5 (9.60)1.000
Table 6 Expression of inflammatory response indicators in the two groups
Indicator
LC + EPBD group (n = 50)
LC + EST group (n = 52)
t
P value
IL-6 (pg/mL)
Preoperative12.96 ± 2.8313.21 ± 3.250.4260.671
48 h postoperatively20.43 ± 3.0224.84 ± 3.516.783< 0.001
IL-10 (pg/mL)
Preoperative17.35 ± 3.9416.21 ± 4.061.4390.153
48 h postoperatively13.43 ± 2.2513.26 ± 2.470.3470.729
TNF-α (pg/mL)
Preoperative18.35 ± 4.3218.92 ± 4.750.6240.534
48 h postoperatively36.36 ± 8.3546.22 ± 8.955.744< 0.001
hs-CRP (mg/L)
Preoperative4.43 ± 1.384.78 ± 1.671.1770.242
48 h postoperatively15.07 ± 3.0418.75 ± 5.164.361< 0.001
PCT (ng/mL)
Preoperative0.35 ± 0.140.32 ± 0.161.0390.301
48 h postoperatively1.42 ± 0.471.51 ± 0.381.0690.290
Table 7 Comparison of liver function indicators in the two groups
Indicator
LC + EPBD group (n = 50)
LC + EST group (n = 52)
t
P value
AST (U/L)
Preoperative 54.72 ± 4.3655.24 ± 5.550.5250.600
3 d postoperatively30.56 ± 5.6441.91 ± 6.039.804< 0.001
ALT (U/L)
Preoperative 72.84 ± 6.9271.43 ± 7.580.9730.333
3 d postoperatively47.94 ± 7.3759.35 ± 7.587.699< 0.001
TBIL (umol/L)
Preoperative 52.14 ± 6.4254.22 ± 7.151.5370.127
3 d postoperatively24.14 ± 6.4527.22 ± 7.052.2930.024